Model
Edge
Ultragenyx Pharmaceutical Inc.
0001713070
Filing Type
4
Filing Date
5/18/2025
Updated
5/19/25, 4:34 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership